|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
FFIN | Anthony April Kaye Bullock | Director | Oct 25 | Buy | 22.90 | 5,000 | 114,500 | 93,146 | Oct 25 04:10 PM |
FFIN | Anthony April Kaye Bullock | Director | Oct 25 | Buy | 36.80 | 5,000 | 184,000 | 85,627 | Oct 26 11:43 AM |
FFIN | Anthony April Kaye Bullock | Director | May 06 | Buy | 40.85 | 5,000 | 204,250 | 80,627 | May 09 01:50 PM |
FFIN | Anthony April Kaye Bullock | Director | May 05 | Buy | 41.00 | 5,000 | 205,000 | 75,627 | May 06 10:15 AM |
FFIN | Anthony April Kaye Bullock | Director | May 03 | Buy | 41.00 | 5,000 | 205,000 | 70,627 | May 05 09:43 AM |
EHC | Anthony April Kaye Bullock | CEO & President, Home Health | May 05 | Option Exercise | 69.23 | 7,583 | 524,943 | 197,772 | May 07 02:00 PM |
FFIN | Anthony April Kaye Bullock | Director | May 14 | Buy | 24.38 | 5,000 | 121,875 | 62,935 | May 15 10:36 AM |
FFIN | Anthony April Kaye Bullock | Director | May 13 | Buy | 24.93 | 10,000 | 249,250 | 57,935 | May 14 10:30 AM |
FFIN | Anthony April Kaye Bullock | Director | May 12 | Buy | 26.00 | 5,000 | 130,000 | 47,935 | May 13 09:52 AM |
EHC | Anthony April Kaye Bullock | CEO & President, Home Health | Mar 12 | Buy | 58.69 | 125,000 | 7,336,848 | 191,740 | Mar 13 03:32 PM |
FFIN | Anthony April Kaye Bullock | Director | Mar 12 | Buy | 21.30 | 10,549 | 224,740 | 40,779 | Mar 12 06:00 PM |
EHC | Anthony April Kaye Bullock | CEO & President, Home Health | Mar 11 | Buy | 64.24 | 40,000 | 2,569,600 | 66,740 | Mar 12 11:03 AM |
FFIN | Anthony April Kaye Bullock | Director | Mar 09 | Buy | 24.00 | 28,256 | 678,144 | 38,486 | Mar 10 12:41 PM |
FFIN | Anthony April Kaye Bullock | Director | Mar 09 | Buy | 24.00 | 19,036 | 456,864 | 24,000 | Mar 10 12:41 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite